Australia markets closed

CervoMed Inc. (CRVO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
15.50-0.37 (-2.33%)
At close: 04:00PM EDT
15.50 0.00 (0.00%)
After hours: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
-
Operating expenses
Research development
9,419
8,438
1,336
8,499
9,428
-
Selling general and administrative
7,646
6,519
2,139
7,445
6,444
-
Total operating expenses
8,982
7,813
3,476
16,038
15,975
-
Operating income or loss
-8,982
-7,813
-3,476
-16,038
-15,975
-
Interest expense
-
0
0.587
-
-
-
Total other income/expenses net
4,565
5,422
-2,389
-8,639
-
-
Income before tax
-4,152
-2,172
-5,803
-24,540
-15,861
-
Income tax expense
-
-
0
-443.893
-1,675
332.885
Income from continuing operations
-4,152
-2,172
-5,803
-24,096
-14,185
-
Net income
-4,152
-2,172
-5,803
-24,096
-14,185
-
Net income available to common shareholders
-4,152
-2,172
-5,803
-24,096
-16,136
-
Basic EPS
-3.10
-0.82
-11.20
-18.57
-22.50
-
Diluted EPS
-5.59
-0.82
-11.20
-18.57
-22.50
-
Basic average shares
2,064
2,661
518.14
1,298
717.759
-
Diluted average shares
2,628
2,661
518.14
1,298
717.759
-